Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: Is it really different, and if so, why?

Journal of Hepatology

Volumn 47, Issue 4, 2007, Pages 447-450

  Degos, Françoise ^a   Tural, Cristina ^b  

^a BEAUJON HOSPITAL   (France)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; DISEASE TRANSMISSION; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIVER CELL CARCINOMA; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER NEOPLASMS; PROGNOSIS;

EID: 34548361774     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.07.011     Document Type: Editorial

References (26)

1. Bräu N., Fox R.K., Xiao P., Marks K., Naqvi Z., Taylor L.E., et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.-Canadian multicenter study. J Hepatol 47 (2007) 527-537
2. Deffic-Burba S., Poynard T., Sulkowski M.S., and Wong J.B. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat 14 (2007) 107-115
3. Powles T., Macdonald D., Nelson M., and Stebbing J. Hepatocellular carcinoma in HIV-infected individuals: tomorrow's problem?. Expert Rev Anticancer Ther 11 (2006) 1553-1558
4. Puoti M., Bruno R., Soriano V., Donato F., Gaeta G.B., Quinzan G.P., et al. Hepatocellular carcinoma in HIV patients: epidemiological features, clinical presentation and outcome. AIDS 18 (2004) 2285-2293
5. Alter M. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44 (2006) S6-S9
6. Rockstroh J.K., Mocroft A., Soriano V., Tural C., Losso M.H., Horban A., et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 192 (2005) 992-1002
7. Gotz H.M., van Doornum G., Niesters H.G., den Hollander J.G., Thio H.B., and de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men - results from contact tracing and public health implications. AIDS 19 (2005) 969-974
8. Rosenthal E., Pialoux G., Bernard N., Pradier C., Rey D., Bentata M., et al. Liver related mortality in human immunodeficiency virus infected patients between 1995 and 2003 in the French GERMIVIC joint study network. J Viral Hepat 14 (2007) 183-188
9. Weber R., Sabin C.A., Friis-Moller N., Reiss P., El-Sadr W.M., Kirk O., et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 166 (2006) 1632-1641
10. Kramer J.R., Giordano T.P., Souchek J., Richardson P., Hwang L.Y., and El Serag H.B. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in US veterans with hepatitis C. Am J Gastroenterol 100 (2005) 56-63
11. Posthouwer D., Makris M., Yee T.T., Fischer K., van Veen J.J., Griffioen A., et al. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood 109 (2007) 3667-3671
12. Giordano T.P., Kramer J.R., Souchek J., Richardson P., and El Serag H.B. Cirrhosis and hepatocellular carcinoma in HIV veterans with and without the hepatitis C virus. Arch Intern Med 164 (2004) 2349-2354
13. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 (2007) 2557-2576
14. Adinolfi L.E., Gambardella M., Andreana A., Tripodi M.F., Utili R., and Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33 (2001) 1358-1364
15. Samaras K., Wand H., Law M., Emery S., Cooper D., and Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care 30 (2007) 113-119
16. Qurishi N., Kreuzberg C., Luchters G., Effenberger W., Kupfer B., Sauerbruch T., et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. The Lancet 362 (2003) 1708-1713
17. Puoti M., Bruno R., Filice G., and Carosi G. Natural history of chronic hepatitis B in coinfected patients. J Hepatol 44 (2006) S65-S70
18. Massard J., Radziu V., Thabut D., Moussali J., Lebray P., Benhamou Y., et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 44 (2006) S19-S24
19. Balasubramanian A., Koziel M., Groopman J.E., and Ganju R.K. Molecular mechanism of hepatic injury in co infection with hepatitis C virus and HIV. Clin Infect Dis 41 (2005) S32-S37
20. Francoz C., Belghiti J., and Durand F. Indications of liver transplantation in patients with complications of cirrhosis. Best Pract Res Clin Gastroenterol 21 (2007) 175-190
21. Ettorre G.M., Vennareecci G., Boschetto A., Giovanelli L., Antonini M., and Carboni F. Resection and transplantation: evaluation of surgical perspectives in HIV positive patients affected by end-stage liver disease. J Exp Clin Cancer Res 22 (2003) S167-S169
22. Bruno R., Puoti M., Sacchi P., Filice C., Carosi G., and Filice G. Management of hepatocellular carcinoma in human immunodeficiency virus infected patients. J Hepatol 44 (2006) S41-S50
23. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. The Lancet 362 (2003) 1907-1917
24. Beaugrand M., Sala M., Degos F., Sherman M., Bolondi L., Evans T., et al. Treatment of advanced hepatocellular carcinoma (HCC) by Seocalcitol (a vitamin D analogue). An international randomized double-blind, placebo-controlled study in 747 patients. J Hepatol 42 (2005) 517
25. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
26. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Raoul J, Zeuzem S, et al. For the SHARP Investigators Study Group. Sorafenib improves survival in advanced Hepatocellular Carcinoma (HCC): Results of a Phase III randomized placebo-controlled trial (SHARP trial). ASCO Proceedings 2007; LBA1.